Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Federal grantsHow to Find Grants for Nonprofits
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to apply for a grantGrant Applications vs. RFPs: Writing Differences Explained
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›Federal
  4. ›Addressing Barriers to Healthcare Transitions for…

U.S. National Institutes of Health·United States of America

Addressing Barriers to Healthcare Transitions for Survivors of Childhood and Adolescent Cancers (R01 Clinical Trial Optional)

Closes 12/9/2025$200k – $500kGrants Notice
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

The National Institutes of Health (NIH) is seeking applications for a funding opportunity to support multi-level intervention studies that address individual and system-level barriers to transition from pediatric to adult care for survivors of childhood and adolescent cancers. The goal of this opportunity is to support the development and testing of interventions and strategies that promote high-quality transitional care and continued engagement of survivors of childhood and adolescent cancers to ensure these survivors receive appropriate surveillance and care into adulthood. Key aspects of this opportunity include: • Supporting research to improve healthcare transitions for survivors of childhood and adolescent cancers • Fostering the development and testing of interventions and strategies to promote high-quality transitional care • Encouraging continued engagement of survivors in their care to ensure they receive appropriate surveillance and treatment into adulthood • Providing funding for applications that propose innovative and effective solutions to address barriers to healthcare transitions • Encouraging collaboration and knowledge-sharing among researchers, healthcare providers, and other stakeholders to advance the field of cancer care and improve outcomes for survivors of childhood and adolescent cancers.

Attached files

Contact

[email protected]

(301) 402-2541

Key dates

Opened
12/16/2024
Closes
12/9/2025

Last updated

Details

Type
Grants Notice
Industry
Healthcare and Medical Services
NAICS
541720
Solicitation №
RFA-CA-25-019

Budget estimate

$200,000 – $500,000

The budget for this grant is not explicitly stated, but based on the NIH's typical funding ranges for similar research grants, it is estimated to be between $200,000 and $500,000 per year for a period of 2-5 years, depending on the scope and complexity of the proposed project. Factors that may influence the likely payment range include the number of awards, the duration of the project, and the NIH's budget for this specific funding opportunity.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. National Institutes of Health·United States of America

Top match · 72%

Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)

Closes 1/7/2027Opened 12/15/2023

U.S. National Institutes of Health·United States of America

72% match

Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)

Closes 2/11/2028Opened 11/7/2024

U.S. National Institutes of Health·United States of America

72% match

National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)

Closes 1/7/2027Opened 12/15/2023

U.S. National Institutes of Health·United States of America

71% match

Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required)

Closes 1/7/2027Opened 4/19/2023

U.S. National Institutes of Health·United States of America

71% match

Research Opportunities in Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed)

Closes 7/5/2029Opened 6/16/2025

U.S. National Institutes of Health·United States of America

71% match

Accelerating Solutions to Improve Access and Quality of Empirically-Supported Practices for Youth Mental Health (R01 Clinical Trial Optional)

Closes 1/7/2027Opened 12/3/2024

U.S. National Institutes of Health·United States of America

70% match

Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional)

Closes 10/25/2027Opened 6/23/2022

U.S. National Institutes of Health·United States of America

70% match

Early-Onset Cancers: Investigating Etiology, Mechanisms, and Early Detection Strategies (RP1 Clinical Trials Optional)

Closes 10/11/2029Opened 3/10/2026

U.S. National Institutes of Health·United States of America

70% match

Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional)

Closes 1/7/2027Opened 8/15/2023

U.S. National Institutes of Health·United States of America

70% match

Advancing Healthcare for Older Adults from Populations that Experience Health Disparities (R01 - Clinical Trial Optional)

Closes 1/7/2028Opened 8/27/2024

U.S. National Institutes of Health·United States of America

69% match

Palliative Care Research Across the Lifespan: Leveraging the Palliative Care Consortium (R01 Clinical Trial Optional)

Closes 11/5/2029Opened 9/29/2025

U.S. National Institutes of Health·United States of America

69% match

Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional)

Closes 10/25/2027Opened 6/23/2022

U.S. National Institutes of Health·United States of America

69% match

Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)

Closes 1/7/2028Opened 11/6/2024

U.S. National Institutes of Health·United States of America

69% match

Limited Competition: NIMHD Initiative for Improving American Indian and Alaska Native Cancer Outcomes (U19 - Clinical Trial Optional)

Closes 1/24/2027Opened 7/16/2026

U.S. National Institutes of Health·United States of America

69% match

NIH Brain Development Cohorts (NBDC) and�Population Assessment of Tobacco and Health (PATH) Study�Biospecimen Access (X01 Clinical Trial Not Allowed)

Closes 4/17/2029Opened 9/10/2025

U.S. National Institutes of Health·United States of America

68% match

Gabriella Miller Kids First Training and Outreach Core (U24 Clinical Trial Not Allowed)

Closes 1/8/2027Opened 5/14/2025

U.S. National Institutes of Health·United States of America

68% match

Single Source: Continued Development of the Gabriella Miller Kids First Pediatric Data Resource Center (U2C Clinical Trial Not Allowed)

Closes 1/8/2027Opened 5/14/2025

U.S. National Institutes of Health·United States of America

68% match

Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)

Closes 10/19/2027Opened 7/2/2025

U.S. National Institutes of Health·United States of America

68% match

Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

Closes 11/10/2026Opened 9/8/2025

U.S. National Institutes of Health·United States of America

68% match

Predoctoral to Postdoctoral Transition Award (Parent F99/K00 - Clinical Trial Not Allowed)

Closes 4/8/2029Opened 6/11/2025

U.S. National Institutes of Health·United States of America

68% match

Mechanisms that Impact Cancer Risk after Bariatric Surgery (R01 Clinical Trial Optional)

Closes 1/7/2028Opened 9/5/2024

U.S. National Institutes of Health·United States of America

68% match

Advanced Development and Sustainment of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)

Closes 6/10/2027Opened 7/28/2026

U.S. National Institutes of Health·United States of America

68% match

Cancer Research Education Grants Program - Research Experiences (R25 Clinical Trial Not Allowed)

Closes 1/7/2027Opened 9/21/2023

U.S. National Institutes of Health·United States of America

68% match

Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)

Closes 11/6/2026Opened 8/1/2023

U.S. National Institutes of Health·United States of America

67% match

NCI Pathway to Independence Award (K99/R00 Clinical Trial Not Allowed)

Closes 10/14/2027Opened 11/20/2024